![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, November 12, 2023 3:18:58 PM
https://ih.advfn.com/stock-market/USOTC/humanigen-ce-HGEN/historical/more-historical-data
The Baudax auditor identified a non-conformance with recording the purchase price of the Tera-Immune acquisition, which I suspect impacts Durrant's ability to adequately reflect that transaction on our 2nd quarter 10-Q.
If you don't want to recognize any other reason for the delay, such as in regards to establishing a strategic advantage for the company, then you should at least consider that Durrant shared the Baudax auditor's opinion, and needs to ensure that he would be in compliance with how he reflects our acquisition of Baudax shares on the last day of Q2.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM